Indian deeptech startups Pixxel, Bellatrix, and Cynlr show promising commercialization progress

Indian deeptech startups like Pixxel, Bellatrix, and Cynlr are making notable progress in commercialization, showcasing their potential in a sector often hindered by funding and structural challenges.

According to industry estimates, funding for deeptech startups in India was just about one-fifth of what flowed into consumer tech ventures in 2024.

Rahul Bajaj, founder of health-tech startup Darwin, emphasized the need for foundational research, stating, “We haven’t invested in foundational research at the scale needed.”

The deeptech sector requires patient capital, as these startups typically need to be evaluated over a 5-10 year horizon, which is significantly longer than the 2-3 years expected from consumer-facing ventures.

Despite these hurdles, the emergence of companies like Pixxel, Bellatrix, and Cynlr indicates a shift towards successful commercialization, suggesting a bright future for India's deeptech landscape.

Indian deeptech startups Pixxel, Bellatrix, and Cynlr are demonstrating significant strides in commercialization, despite facing challenges such as funding gaps and the need for patient capital, which is crucial for their long-term growth and development in a competitive market.